Family Medicine Experts & Viewpoints

 

POLL

A new bill in Congress would send trained clinicians into doctors’ offices with independent data about the relative benefits, risks, and costs of drugs; some research suggests that such "academic detailing" reduces potential prescribing bias from the influence of drug company reps. What effect do you think such a program would have?
Would significantly reduce bias
Would somewhat reduce bias
Would not reduce bias
Uncertain
My prescribing decisions are not influenced by drug company representatives
Related Link: Senate press release
 
 
 

Featured Viewpoint

 
  • Retooling for an Aging America Harvey V. Fineberg, MD, President, Institute of Medicine, Washington, DC, discusses the impact of the "baby boomer" generation on medicine.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.